Ashlyn Bassiri, PhD
Vice President, Immunology
Ashlyn Bassiri is the Vice President of Immunology at Kriya Therapeutics. Dr. Bassiri joins Kriya from CSL Behring where she was the Head of Translational Safety. Prior to that, she was the Pharmacovigilance Leader for all liver-targeted programs and supported the US and European filings for LUXTURNA® at the Philadelphia-based gene therapy company, Spark Therapeutics. She spent ten years in R&D at GlaxoSmithKline where she focused on immune toxicities in both the nonclinical and clinical safety groups, eventually chairing the Immune Safety panel.
Dr. Bassiri received her PhD in immunology from the University of Pennsylvania School of Medicine. She received her master’s and undergraduate degrees in Biomedical Sciences and Immunology from Ohio University.